Gemzar shows efficacy in breast cancer, says Eli Lilly
The study evaluated the addition of Gemzar to the current standard-of-care of epirubicin and cyclophosphamide followed by Taxol (paclitaxel) in patients with stage II-III breast cancer. The treatment